These findings also lend support to the increase in FFM during the active stage of the VLCKD and show the usefulness of the HGS test in the nutritional management of patients with obesity as a possible additional diagnostic tool to CRP to evaluate changes in the inflammation status and the correct planning of the VLCKD protocol stages. Here, CRP is linked to obesity due to melanocortin 4 receptor deficiency.